KRSNAA DIAGNOSTICS
|
|
| BOM : 543328     NSE : KRSNAA     | |
| LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 22,2026 |
|
Price(EOD): ₹ 562.00
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 1,820.88 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KRSNAA DIAGNOSTICS | -0.4% | -7% | -13% |
| APOLLO HOSPITALS ENTERPRISE | 4.2% | 9.1% | 19% |
| MAX HEALTHCARE INSTITUTE | -3.3% | 1.8% | -8.1% |
| FORTIS HEALTHCARE | -0.2% | 4% | 41.1% |
| ASTER DM HEALTHCARE | 0.2% | 10.5% | 29.8% |
| NARAYANA HRUDAYALAYA | -0.7% | 2.3% | 10.1% |
| GLOBAL HEALTH | -0.1% | 11.6% | 4.8% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 6.5% | 12.1% | 19.5% |
| DR LAL PATHLABS | -1.2% | 11.6% | 20.2% |
FUNDAMENTAL ANALYSIS OF KRSNAA DIAGNOSTICS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KRSNAA DIAGNOSTICS
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
22.66
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 80.45 Cr
[Latest Qtr - Dec2025 - Consolidated Results ] 2.08
P/B Calculated based on Book Value of Rs 876.33 Cr
[Latest Year - Mar2025 - Consolidated Results ] 2.38
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 766.25 Cr
[Latest Qtr - Dec2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
18% 9% -34% |
SHARE PRICE MOMENTUM OF KRSNAA DIAGNOSTICS
KRSNAA DIAGNOSTICS vs SENSEX
DEBT OF KRSNAA DIAGNOSTICS
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.23 0.2 0.04 0.16 |
0.23 0.2 0.04 0.16 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF KRSNAA DIAGNOSTICS
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF KRSNAA DIAGNOSTICS
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-12.03% -21.49% -37.35% -35.96% |
3.83% 3.03% -22.42% -21.05% |
| QtrlyTrend |
-4 | |
| Latest Qtr: Dec2025 | ||
| Quarterly Result Analysis → | ||
KRSNAA DIAGNOSTICS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 1000 | 0.5% | -1.6% | -1.3% |
| BSE HEALTHCARE | 0.2% | 8.8% | 11.4% |
You may also like the below Video Courses
FAQ about KRSNAA DIAGNOSTICS
Is KRSNAA DIAGNOSTICS good for long term investment?
As on May 22,2026, the Fundamentals of KRSNAA DIAGNOSTICS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of KRSNAA DIAGNOSTICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KRSNAA DIAGNOSTICS UnderValued or OverValued?
As on May 22,2026, KRSNAA DIAGNOSTICS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of KRSNAA DIAGNOSTICS ?
As on May 22,2026, the Intrinsic Value of KRSNAA DIAGNOSTICS is Rs. 514.17 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 475.05
Fair Value [Median EV / Sales Model] : Rs. 514.17
Fair Value [Median Price / Sales Model] : Rs. 851.02
Estimated Median Fair Value of KRSNAA DIAGNOSTICS : Rs. 514.17
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.